Advertisement
Table 1 Distribution of age and HPV prevalence in enrolled patients
| characteristics | HPV positive rate in 2612 women | HR-HPV rate in CIN group |
|---|---|---|
| Age | ||
| ≤ 29 | 209(80.7%) | 92(35.5%) |
| 30–34 | 211(70.1%) | 106(35.2%) |
| 35–39 | 182(59.1%) | 103(33.4%) |
| 40–44 | 221(49.6%) | 124(27.8%) |
| 45–49 | 166(32.0%) | 89(17.1%) |
| 50–54 | 149(35.6%) | 76(18.2%) |
| 55–59 | 54(41.2%) | 27(20.6%) |
| 60–64 | 54(45.0%) | 32(26.7%) |
| 65–69 | 27(55.1%) | 19(38.8%) |
| ≥ 70 | 23(37.7%) | 19(31.1%) |
| HPV | ||
| Single-type infection | 950(73.3%) | |
| Multiple-type infection | 346(26.70%) | |
| 2 types | 252(72.80%) | |
| 3 types | 68(19.70%) | |
| 4 types | 19(5.50%) | |
| 5 types | 5(1.40%) | |
| 6 types | 2(0.60%) | |
| HR-multiple | 218(63.00%) | |
| LR-multiple | 8(2.30%) | |
| HR-LR multiple | 120(34.70%) | |
